4.6 Review

Impact of immune cells on the hallmarks of cancer: A literature review

Journal

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 168, Issue -, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2021.103541

Keywords

Cancer; Immune system; Tumor-infiltrating immune cells (TIICs); Prognosis; Immunotherapy

Funding

  1. Portuguese League Against Can-cer-Regional Nucleus of the North (Liga Portuguesa Contra o Can-cro-Nucleo Regional do Norte)
  2. Research Center of the Portuguese Oncology Institute of Porto [PI86-CI-IPOP-66-2017]
  3. Laboratory for Process Engineering, Environment, Biotechnology, and Ener-gy-LEPABE - FCT/MCTES (PIDDAC) [UIDB/00511/2020]
  4. Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/135871/2018]
  5. European Social Funds (FSE)
  6. MCTES
  7. Fundação para a Ciência e a Tecnologia [SFRH/BD/135871/2018] Funding Source: FCT

Ask authors/readers for more resources

Tumor-infiltrating immune cells play critical roles in the tumor microenvironment, contributing to the establishment of various cancer hallmarks and serving as potential therapeutic targets. Additional studies are needed to explore the therapeutic potential of TIICs and improve cancer patient outcomes.
Tumor-infiltrating immune cells (TIICs) are critical players in the tumor microenvironment, modulating cancer cell functions. TIICs are highly heterogenic and plastic and may either suppress cancers or provide support for tumor growth. A wide range of studies have shed light on how tumor-associated macrophages, dendritic cells, neutrophils, mast cells, natural killer cells and lymphocytes contribute for the establishment of several hallmarks of cancer and became the basis for successful immunotherapies. Many of those TIICs play pivotal roles in several hallmarks of cancer. This review contributes to elucidate the multifaceted roles of immune cells in cancer development, highlighting molecular components that constitute promising therapeutic targets. Additional studies are needed to clarify the relation between TIICs and hallmarks such as enabling replicative immortality, evading growth suppressors, sustaining proliferative signaling, resisting cell death and genome instability and mutation, to further explore their therapeutic potential and improve the outcomes of cancer patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available